Thalidomide-O-amido-PEG4-azide
Thalidomide-O-amido-PEG4-azide Basic information
- Product Name:
- Thalidomide-O-amido-PEG4-azide
- Synonyms:
-
- Thalidomide-O-amido-PEG4-azide
- Acetamide, N-(14-azido-3,6,9,12-tetraoxatetradec-1-yl)-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
- N-(14-Azido-3,6,9,12-tetraoxatetradecyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide
- CAS:
- 2411681-89-3
- MF:
- C25H32N6O10
- MW:
- 576.56
- Mol File:
- 2411681-89-3.mol
Thalidomide-O-amido-PEG4-azide Chemical Properties
- storage temp.
- -20°C, sealed storage, away from moisture
- form
- Solid
- color
- White to off-white
Thalidomide-O-amido-PEG4-azide Usage And Synthesis
Description
Thalidomide-O-amido-PEG4-azide is a PROTAC linker that is reactive with alkyne or DBCO, BCN attached molecule via click chemistry, PEG space increase compound solubility.
Uses
Thalidomide-O-amido-PEG4-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Thalidomide-O-amido-PEG4-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
IC 50
Cereblon
References
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005
Thalidomide-O-amido-PEG4-azideSupplier
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 0371-0371-55629727 13323845623
- 2885676761@qq.com
- Tel
- +86-156-80926068 +86-15680926068
- 1924344760@qq.com
- Tel
- 13504435624
- 1927928688@qq.com
- Tel
- +1-5166625404;
- Info@alfa-chemistry.com
Thalidomide-O-amido-PEG4-azide(2411681-89-3)Related Product Information
- Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride
- Thalidomide-linker 14
- Thalidomide-linker 13
- N-(4-azidobutyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide
- E3 Ligase Ligand-Linker Conjugates 20
- E3 Ligase Ligand-Linker Conjugates 21
- E3 Ligase Ligand-Linker Conjugates 19
- Thalidomide-O-amido-C4-NH2 hydrochloride
- Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride
- Thalidomide-linker 15
- Thalidomide-O-amido-C8-NH2 hydrochloride
- Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2
- N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide Trifluoroacetate
- E3 Ligase Ligand-Linker Conjugates 24 (TFA)
- Acetamide, N-(5-aminopentyl)-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
- Thalidomide-O-amido-PEG5-NH2 hydrochloride
- Thalidomide-O-C10-NH2 hydrochloride
- 1H-Isoindole-1,3(2H)-dione, 4-[(8-aminooctyl)oxy]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1)